Friday, February 26, 2016 7:52:21 PM
and in addition to LymPro & MSPrecise, Gerald stated they were seeking to spin ESS off as well
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=120700727&txt2find=ESS
that just leaves MANF, Eltoprazene, PhenoGuard & the GeorgeTown Assays
forget NuroPro and SeraPro, their both completely worthless
AMBS is imploding under the crushing weight of massive convertibles
and there seems to be no way out from underneath it
the FDA isn't giving out many Rare Pediatric Disease Designation (RPDD) vouchers for orphan drugs anymore
and I think Gerald & the esteemed BOD intuitively know their in over their heads
and have been strategizing for the exits...
AJMHO
FEATURED Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • Jun 14, 2024 2:07 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM
Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM